For the Inventor, By the Inventor

Enter assignee name

Philadelphia, PA, United States of America

Smithkline Corporation

USPTO Granted Patents = 344

Trademarks = 5

Forward Citations = 2,120

Loading Chart...

Loading Chart...

140 inventors (with patents filed for the assignee):

David A Berges (52 out of 56 patents)

John G Gleason (31 out of 66 patents)

Carl Kaiser (25 out of 46 patents)

4. Joseph Weinstock (21 out of 65 patents)

5. Bernard Loev (21 out of 22 patents)

6. John R Hoover (21 out of 25 patents)

7. Robert M DeMarinis (20 out of 35 patents)

8. David T Hill (20 out of 43 patents)

9. Kenneth G Holden (20 out of 21 patents)

10. L Martin Brenner (13 out of 13 patents)

11. Kenneth M Snader (13 out of 16 patents)

12. Ivan Lantos (12 out of 19 patents)

13. Paul E Bender (11 out of 44 patents)

14. Robert G Pendleton (11 out of 11 patents)

15. Blaine M Sutton (11 out of 11 patents)

Core Competencies:

Amide Compounds

Pharmaceutical Compositions

Dopaminergic Isoquinolines

Antiallergic Imidodisulfamides

Renal Vasodilating Agents

Guanidinopyrimidine Compounds

Anthracycline Antibiotics

Tetrahydroisoquinolines

Thienylmethyl Compounds

Cephalosporins

Hydroxyphenylpyridazinones

Thiazole Derivatives

344 patents: Sort by Forward Citations

1. 7247748 - Amide compounds and methods of using the same (2007-07-24),

2. 6331631 - Preparation of 1-butyl-4-piperidinylmethylamine (2001-12-18),

3. 4353902 - Livestock feed and method for improving food utilization (1982-10-12),

4. 4352809 - Method of producing alpha.sub.2 antagonism (1982-10-05),

5. 4352754 - 3-Thienylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1 (1982-10-05),

6. 4350698 - Antiallergic imidosulfamides (1982-09-21),

7. 4350685 - Antiallergic imidodisulfamides (1982-09-21),

8. 4342686 - Intermediates for preparing 6-lower (1982-08-03),

9. 4341786 - Pharmaceutical compositions and method of producing central alpha.sub.1 (1982-07-27),

10. 4340733 - Process for preparing 3-chloro-6-(2-hydroxyphenyl)-pyridazines (1982-07-20),

11. 4340601 - Dopaminergic isoquinolines (1982-07-20),

12. 4340600 - Renal dilating methods and compositions using (1982-07-20),

13. 4336255 - Pharmaceutical compositions containing guanidinopyrimidines (1982-06-22),

14. 4336254 - Guanidinopyrimidine compounds, compositions and method of using as a (1982-06-22),

15. 4328153 - Dopaminergic benzazepines (1982-05-04),

SmithKline Corporation is a leading pharmaceutical company that focuses on research, development, and manufacturing of innovative healthcare products. With a vision to improve the quality of life for people worldwide, SmithKline Corporation is committed to delivering safe and effective therapies across various therapeutic areas. Through cutting-edge technologies and expertise, they aim to address unmet medical needs and provide transformative solutions. Visit their website to learn more about their products and initiatives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

344 Patents

#9 in Philadelphia, PA

#49 in Pennsylvania

#1,261 in US

#2,559 in the World

Philadelphia, PA, United States of America

Smithkline Corporation

Forward Citations = 2,120

140 inventors:

David A Berges (52 out of 56 patents)

John G Gleason (31 out of 66 patents)

Carl Kaiser (25 out of 46 patents)

4. Joseph Weinstock (21 out of 65 patents)

5. Bernard Loev (21 out of 22 patents)

Please report any incorrect information to support@idiyas.com

Loading…